Open AccessEffect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Author(s) -
Ofri Mosenzon,
Gil Leibowitz,
Deepak L. Bhatt,
Avivit Cahn,
Boaz Hirshberg,
Cheryl Wei,
KyungAh Im,
Aliza Rozenberg,
Ilan Yanuv,
Christina Stahre,
Kausik K. Ray,
Nayyar Iqbal,
Eugene Braunwald,
Benjamin M. Scirica,
Itamar Raz
Publication year - 2016
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc16-0621
Subject(s) - saxagliptin , medicine , timi , diabetes mellitus , intensive care medicine , type 2 diabetes , endocrinology , myocardial infarction , sitagliptin , percutaneous coronary intervention
Dipeptidyl peptidase 4 inhibitors may have a protective effect in diabetic nephropathy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom